Award recordCONTRACT

BIOIMMUNO TECH COMPANY

PIID VA549D10043· VHA· 549-DALLAS· 6550 · IN VITRO DIAGNO SUBSTANCES,REAGENTS· FY2011· $3,250 net obligations· UEI XHZEBYDAG8Q9· TX

Description

SUPPLIES EMBEDDING RAT

First action · last action
2011-09-06 · 2011-09-06
Transactions
1
First transaction's obligation
$3,250
Base + all options value (sum of deltas)
$3,250
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
621511 · MEDICAL LABORATORIES

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$3,250$0Base award · 2011-09-06 · this action $3,250 · running total $3,250
  • Base2011-09-06+$3,250= $3,250
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-09-06+$3,250$3,250SUPPLIES EMBEDDING RAT

Related awards · 5

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other recipients under 6550 from 549-DALLAS (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25712P0586MICROGENICS CORPORATION549-DALLAS$3,370FY2012
VA25712J0362IMMUCOR INC549-DALLAS$10,614FY2012
VA25712P0337GEN-PROBE INCORPORATED549-DALLAS$4,365FY2012
VA25712J0043SIEMENS HEALTHCARE DIAGNOSTICS INC.549-DALLAS$24,883FY2012
VA25712F0077ROCHE DIAGNOSTICS CORPORATION549-DALLAS$29,369FY2012

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA549D10043_3600_-NONE-_-NONE- · retrieved 2026-09-26.